GLP-1 Side Effects: What the Four Labels Say
Side effects, serious warnings, and the surgery, pill and pregnancy lines from the US labels of Ozempic, Wegovy, Mounjaro and Zepbound, side by side.
- 1Nausea tops all four side-effect tables; people on placebo reported it far less.1,2,3,4
- 2All four share nearly the same serious warnings, including rare cases of stomach contents reaching the lungs under anesthesia.1,2,3,4
- 3Only Mounjaro and Zepbound warn that the birth control pill may work less well.1,2,3,4
The short answer
Ozempic and Wegovy are the same drug, semaglutide. Mounjaro and Zepbound share another, tirzepatide.1,2,3,4 Each US label counts side effects in its own trials. Stomach trouble leads all four lists, and nausea comes first. People on placebo, a dummy shot, reported it far less.1,2,3,4 One catch: Ozempic's and Mounjaro's numbers come from diabetes trials, Wegovy's and Zepbound's from weight-loss trials.1,2,3,4 So compare each drug only with its own placebo.
| Ozempic | Wegovy | Mounjaro | Zepbound | |
|---|---|---|---|---|
| Trials | Diabetes | Weight loss | Diabetes | Weight loss |
| Nausea | 16 to 20 (6) | 44 (16) | 12 to 18 (4) | 25 to 29 (8) |
| Diarrhea | 9 (2) | 30 (16) | 12 to 17 (9) | 19 to 23 (8) |
| Vomiting | 5 to 9 (2) | 24 (6) | 5 to 9 (2) | 8 to 13 (2) |
| Constipation | 3 to 5 (2) | 24 (11) | 6 to 7 (1) | 11 to 17 (5) |
| Belly pain | 6 to 7 (5) | 20 (10) | 5 to 6 (4) | 9 to 10 (5) |
- Ozempic
- Diabetes
- Wegovy
- Weight loss
- Mounjaro
- Diabetes
- Zepbound
- Weight loss
- Ozempic
- 16 to 20 (6)
- Wegovy
- 44 (16)
- Mounjaro
- 12 to 18 (4)
- Zepbound
- 25 to 29 (8)
- Ozempic
- 9 (2)
- Wegovy
- 30 (16)
- Mounjaro
- 12 to 17 (9)
- Zepbound
- 19 to 23 (8)
- Ozempic
- 5 to 9 (2)
- Wegovy
- 24 (6)
- Mounjaro
- 5 to 9 (2)
- Zepbound
- 8 to 13 (2)
- Ozempic
- 3 to 5 (2)
- Wegovy
- 24 (11)
- Mounjaro
- 6 to 7 (1)
- Zepbound
- 11 to 17 (5)
- Ozempic
- 6 to 7 (5)
- Wegovy
- 20 (10)
- Mounjaro
- 5 to 6 (4)
- Zepbound
- 9 to 10 (5)
From each label's section 6.1. A range spans the label's drug groups. The trials differ in people and length, so compare each number only with its own placebo figure. Ozempic's decimals are rounded.
The full PDF, free.
- The common side effects from all four labels next to placebo, how many people stopped over them, and what Wegovy's highest strength adds.
- A warnings table: what all four share, what only one carries, and what was removed in 2026.
- Surgery, other pills, the birth control pill, pregnancy and breastfeeding, label by label.
- The eye risk Europe lists for semaglutide that the US labels do not mention.
A source on every line. No paid placements. No doses.
This guide was last checked on 28 October 2026. Research and educational information only. Nothing here is medical advice.
- [1] Ozempic label (Novo Nordisk, revised May 2026) (opens in new tab). Checked 28 Oct 2026Back to text (first mention of source 1)
- [2] Wegovy label (Novo Nordisk, revised June 2026) (opens in new tab). Checked 28 Oct 2026Back to text (first mention of source 2)
- [3] Mounjaro label (Eli Lilly, revised Aug 2026) (opens in new tab). Checked 28 Oct 2026Back to text (first mention of source 3)
- [4] Zepbound label (Eli Lilly, revised Aug 2026) (opens in new tab). Checked 28 Oct 2026Back to text (first mention of source 4)
- [5] FDA Drug Safety Communication, 13 Jan 2026 (current as of 3 Apr 2026): removal of the suicidal behavior and ideation warning from GLP-1 labels (opens in new tab). Checked 28 Oct 2026
- [6] European Medicines Agency, PRAC conclusion on NAION and semaglutide, 6 Jun 2025 (revised 13 Jun 2025) (opens in new tab). Checked 28 Oct 2026
- [7] FDA label database (openFDA): full-text search of the four labels for NAION, optic and nonarteritic, 28 Oct 2026 (opens in new tab). Checked 28 Oct 2026
More free guides
- Stopping a GLP-1: What the Trials ShowThree big trials that tested stopping semaglutide or tirzepatide, side by side, with what came back and how fast.Open
- Retatrutide: Real Trials, Unknown VialsLilly's retatrutide trials in one table, kept apart from the vials sold under its name.Open
- Peptides 101: What's Tested, What Isn'tWhat a peptide is, plus one map of eleven peptides: approved, tested in people, or barely tested.Open